Sign in or create an account to add this stock to your watchlist.
About Global Medical REIT (NYSE:GMRE)
Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company's management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers. The Company elected to be taxed as a REIT for U.S. federal income tax purposes commencing with its taxable year ending December 31, 2016.
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
SymbolNYSE:GMRE
CUSIPN/A
Phone202-524-6851
Debt
Debt-to-Equity Ratio1.31
Current Ratio0.17
Quick Ratio0.17
Price-To-Earnings
Trailing P/E Ratio16.35
Forward P/E Ratio10.77
P/E Growth1.19
Sales & Book Value
Annual Sales$30.34 million
Price / Sales6.30
Cash Flow$0.5231 per share
Price / Cash16.88
Book Value$8.31 per share
Price / Book1.06
Profitability
EPS (Most Recent Fiscal Year)$0.54
Net Income$-30,000.00
Net Margins7.75%
Return on Equity1.61%
Return on Assets0.64%
Miscellaneous
Employees9
Outstanding Shares21,630,000
Global Medical REIT (NYSE:GMRE) Frequently Asked Questions
What is Global Medical REIT's stock symbol?
Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."
How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?
Global Medical REIT declared a quarterly dividend on Thursday, March 8th. Stockholders of record on Thursday, March 22nd will be paid a dividend of $0.20 per share on Tuesday, April 10th. This represents a $0.80 annualized dividend and a dividend yield of 9.06%. The ex-dividend date is Wednesday, March 21st. View Global Medical REIT's Dividend History.
How were Global Medical REIT's earnings last quarter?
Global Medical REIT (NYSE:GMRE) posted its quarterly earnings data on Tuesday, May, 8th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.04 by $0.02. The company had revenue of $11.56 million for the quarter, compared to analyst estimates of $11.50 million. Global Medical REIT had a return on equity of 1.61% and a net margin of 7.75%. View Global Medical REIT's Earnings History.
When is Global Medical REIT's next earnings date?
What price target have analysts set for GMRE?
4 brokers have issued 12 month target prices for Global Medical REIT's shares. Their forecasts range from $8.00 to $12.00. On average, they expect Global Medical REIT's stock price to reach $10.1250 in the next year. View Analyst Ratings for Global Medical REIT.
What are Wall Street analysts saying about Global Medical REIT stock?
Here are some recent quotes from research analysts about Global Medical REIT stock:
- 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (5/11/2018)
- 2. Cantor Fitzgerald analysts commented, "GMRE reported in-line 4Q17 results in a relatively clean but active quarter in terms of M&A and balance sheet developments." (3/7/2018)
Who are some of Global Medical REIT's key competitors?
Some companies that are related to Global Medical REIT include InterRent REIT (IIPZF), Pennsylvania Real Estate Investment Trust (PEI), istar (STAR), NorthStar Realty Europe (NRE), Ashford Hospitality Trust (AHT), NY Mtg Tr Inc/SH (NYMT), CIM Commercial Trust (CMCT), Urstadt Biddle Properties (UBP), New Senior Investment Group (SNR), INVESTORS REAL ESTATE TRUST REIT Common Stock (IRET), CatchMark Timber Trust (CTT), ARBOR Rlty Tr I/SH (ABR), NexPoint Residential Trust (NXRT), Preferred Apartment Communities (APTS) and UMH Properties (UMH).
Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the folowing people:
- Mr. Jeffrey M. Busch, Chairman, CEO & Pres (Age 58)
- Mr. David A. Young, Consultant (Age 70)
- Mr. Robert J. Kiernan, CFO & Treasurer (Age 52)
- Ms. Danica Holley, Chief Operating Officer (Age 45)
- Mr. Alfonzo Leon, Chief Investment Officer (Age 42)
When did Global Medical REIT IPO?
(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.
Has Global Medical REIT been receiving favorable news coverage?
News articles about GMRE stock have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Global Medical REIT earned a media sentiment score of 0.12 on Accern's scale. They also assigned media stories about the company an impact score of 46.64 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are Global Medical REIT's major shareholders?
Global Medical REIT's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.01%), Resource America Inc. (2.23%), State of Wisconsin Investment Board (1.39%), Manning & Napier Group LLC (1.18%), Millennium Management LLC (1.06%) and Stifel Financial Corp (0.88%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch, Matthew Cypher and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.
Which institutional investors are selling Global Medical REIT stock?
GMRE stock was sold by a variety of institutional investors in the last quarter, including Resource America Inc., Manning & Napier Group LLC, State of Wisconsin Investment Board, Oppenheimer & Co. Inc., BB&T Securities LLC, Rational Advisors LLC and B. Riley Financial Inc.. View Insider Buying and Selling for Global Medical REIT.
Which institutional investors are buying Global Medical REIT stock?
GMRE stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, GSA Capital Partners LLP, Stifel Financial Corp, BlackRock Inc., Citigroup Inc., Dimensional Fund Advisors LP, D.A. Davidson & CO. and A.R.T. Advisors LLC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, Matthew Cypher and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.
How do I buy shares of Global Medical REIT?
Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Medical REIT's stock price today?
One share of GMRE stock can currently be purchased for approximately $8.83.
How big of a company is Global Medical REIT?
Global Medical REIT has a market capitalization of $191 million and generates $30.34 million in revenue each year. The company earns $-30,000.00 in net income (profit) each year or $0.54 on an earnings per share basis. Global Medical REIT employs 9 workers across the globe.
How can I contact Global Medical REIT?
Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.
MarketBeat Community Rating for Global Medical REIT (GMRE)
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
Global Medical REIT (NYSE:GMRE) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Global Medical REIT in the last 12 months. Their average twelve-month price target is $10.1250, suggesting that the stock has a possible upside of 14.67%. The high price target for GMRE is $12.00 and the low price target for GMRE is $8.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 2.80 | 2.83 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $10.1250 | $10.25 | $10.75 | $10.75 |
| Price Target Upside: | 14.67% upside | 47.69% upside | 14.67% upside | 14.67% upside |
Global Medical REIT (NYSE:GMRE) Consensus Price Target History
Global Medical REIT (NYSE:GMRE) Analyst Ratings History
Show:
(Data available from 5/28/2016 forward)
Global Medical REIT (NYSE:GMRE) Dividend Information
Global Medical REIT pays an annual dividend of $0.80 per share, with a dividend yield of 9.06%. GMRE's most recent quarterly dividend payment was Tuesday, April 10. Global Medical REIT pays out 148.15% of its earnings out as a dividend.
| Most Recent Dividend: | 4/10/2018 |
| Annual Dividend: | $0.80 |
| Dividend Yield: | 9.06% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio(s): | 148.15% (Trailing 12 Months of Earnings)
97.56% (Based on This Year's Estimates)
90.91% (Based on Next Year's Estimates)
152.93% (Based on Cash Flow)
|
Global Medical REIT (NYSE:GMRE) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/8/2018 | quarterly | $0.20 | 11.27% | 3/21/2018 | 3/22/2018 | 4/10/2018 |
| 12/15/2017 | Quarterly | $0.20 | 9.3% | 12/22/2017 | 12/26/2017 | 1/10/2018 |
| 9/8/2017 | Quarterly | $0.20 | 8.68% | 9/25/2017 | 9/26/2017 | 10/9/2017 |
| 6/16/2017 | Quarterly | $0.20 | 8.28% | 6/23/2017 | 6/27/2017 | 7/10/2017 |
| 3/20/2017 | Quarterly | $0.20 | 9.7% | 3/23/2017 | 3/27/2017 | 4/10/2017 |
| 12/14/2016 | Quarterly | $0.20 | 8.42% | 12/22/2016 | 12/27/2016 | 1/10/2017 |
| 9/14/2016 | Quarterly | $0.20 | | 9/23/2016 | 9/27/2016 | 10/11/2016 |
(Data available from 1/1/2013 forward)
Global Medical REIT (NYSE GMRE) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 13.00%
Institutional Ownership Percentage: 38.87%
Global Medical REIT (NYSE GMRE) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/11/2018 | Matthew Cypher | Director | Buy | 475 | $8.41 | $3,994.75 | |  |
| 3/13/2018 | Jeffrey Busch | Chairman | Buy | 6,000 | $7.13 | $42,780.00 | | |
| 11/14/2017 | Henry Cole | Director | Buy | 1,000 | $9.30 | $9,300.00 | | |
| 11/14/2017 | Jeffrey Busch | Chairman | Buy | 2,630 | $9.29 | $24,432.70 | | |
| 6/30/2017 | Jeffrey Busch | Chairman | Buy | 11,100 | $9.00 | $99,900.00 | 20,110 | |
| 7/1/2016 | Jeffrey Busch | Chairman | Buy | 9,000 | $10.01 | $90,090.00 | 9,000 | |
| 7/1/2016 | Zh Usa, Llc | Major Shareholder | Buy | 1,179,019 | $12.75 | $15,032,492.25 | 2,604,500 | |
(Data available from 1/1/2013 forward)
Global Medical REIT (NYSE GMRE) News Headlines
| Source: |
|
Global Medical REIT (NYSE:GMRE) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Global Medical REIT (NYSE GMRE) Stock Chart for Monday, May, 28, 2018
Loading chart…
